APOE and atherosclerosis: E2 and statin co-treatment significantly decreased lipid accumulation in vitro, after HFD consumption for 12 weeks, administration of E2 and a statin together significantly relieved blood-lipid disorders and hindered progression of atherosclerosis and fatty-liver damage in OVX ApoE–/– mice.